GlassScriptPhysician profile
Keiko Suzuki
NPI 1437389376
$1,719.32
in general payments reported to CMS, 2019-2025
20 companies · $80.59 in 2025
The $80.59 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $290 · 2021: $407 · 2022: $108 · 2023: $167 · 2024: $204 · 2025: $80.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $603.70 | 2019-2025 | Trelegy Ellipta, Shingrix |
| Abbvie INC. | $238.49 | 2021-2024 | Vraylar |
| Pfizer INC. | $163.21 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.41 | 2019-2024 | Jardiance, Synjardy |
| Astrazeneca Pharmaceuticals LP | $120.71 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $78.02 | 2023-2025 | Mounjaro, Zepbound |
| Esperion Therapeutics, INC. | $61.16 | 2020-2021 | |
| Amgen INC. | $55.56 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $34.00 | 2020 | |
| Exact Sciences Corporation | $30.23 | 2023-2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $27.89 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $23.79 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $22.98 | 2020 | |
| Merck Sharp & Dohme LLC | $18.05 | 2025 | Enflonsia |
| Genentech USA, INC. | $14.71 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $14.26 | 2021 | |
| Medtronic, INC. | $13.64 | 2025 | Intellis Adaptivestim |
| Biohaven Pharmaceuticals, INC. | $13.61 | 2021 | |
| Sanofi Pasteur INC. | $12.95 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.95 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keiko Suzuki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.